BLK
BlackRock, Inc.
BLK's fundamentals are mixed, but it looks expensive: trading at 28x earnings, above its usual 22x.
CPBI
Central Plains Bancshares, Inc. Common Stock
There isn't enough reported data to score CPBI yet.
BLK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BLK's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BLK.
CPBI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
CPBI's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like CPBI.
BLK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 19x | $848 | -30% |
| Fair | 22x | $973 | -20% |
| Expensive | 26x | $1,149 | -5.5% |
| Current | 28x | $1,217 | — |
Historical ranges are pointers, not guarantees.
BLK's PE is in its expensive range at 28x.
CPBI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $19.23 | -7.2% |
| Fair | 17x | $20.27 | -2.2% |
| Expensive | 18x | $21.33 | +2.9% |
| Current | 18x | $20.73 | — |
Historical ranges are pointers, not guarantees.
CPBI has the edge over BLK in the historical PE scenario, which offers more potential upside but is not a forecast.
BLK Forward outlook
There aren't enough analyst estimates for BLK to show an outlook.
CPBI Forward outlook
There aren't enough analyst estimates for CPBI to show an outlook.
BLK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $43.87 | +11% |
| Q2 2026 | $41.73 | -0.4% |
| Q1 2026 | $39.73 | -4.7% |
| Q4 2025 | $35.31 | -17% |
| Q3 2025 | $39.42 | -2.7% |
| Q2 2025 | $41.89 | +4% |
| Q1 2025 | $41.69 | +5.9% |
| Q4 2024 | $42.53 | +16% |
BLK earned $43.87 per share over the past year, up 11% from the year before.
CPBI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $1.18 | +20% |
| Q1 2026 | $1.05 | +9.4% |
CPBI has the edge over BLK in the latest year-over-year earnings comparison.
BLK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.8B | +19% |
| Q2 2026 | $7.1B | +31% |
| Q1 2026 | $6.7B | +27% |
| Q4 2025 | $7B | +23% |
| Q3 2025 | $6.5B | +25% |
| Q2 2025 | $5.4B | +13% |
| Q1 2025 | $5.3B | +12% |
| Q4 2024 | $5.7B | +23% |
BLK has the edge over CPBI on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | 0 points |
| Q2 2026 | 35% | +2.8 points |
| Q1 2026 | 42% | +9.8 points |
| Q4 2025 | 24% | -13 points |
| Q3 2025 | 30% | -8.6 points |
| Q2 2025 | 32% | -5.5 points |
| Q1 2025 | 32% | -3.6 points |
| Q4 2024 | 37% | +2.3 points |
BLK has the edge over CPBI on profitability, with a higher operating margin.
CPBI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $8.3M | +15% |
| Q1 2026 | $7.8M | +9.1% |
| Q4 2025 | $7.9M | +14% |
| Q3 2025 | $7.5M | +10% |
| Q2 2025 | $7.2M | +11% |
| Q1 2025 | $7.1M | +12% |
| Q4 2024 | $6.9M | +9% |
| Q3 2024 | $6.8M | +19% |
CPBI's revenue has grown year over year every quarter since late 2023: $8M last quarter, up 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 22% | +5.2 points |
| Q1 2026 | 15% | +0.1 points |
| Q4 2025 | 19% | +1.5 points |
| Q3 2025 | 15% | -2.1 points |
| Q2 2025 | 17% | 0 points |
| Q1 2025 | 15% | -1.9 points |
| Q4 2024 | 17% | -1 points |
| Q3 2024 | 17% | -4.5 points |
CPBI's operating margin was 22% last quarter, up 5.2 points from the same quarter a year ago, near the top of its range since 2023.
BLK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.6B | +95% |
| Q2 2026 | $1.1B | -12% |
| Q1 2026 | -$1.1B | +$120M |
| Q4 2025 | $2.1B | -15% |
| Q2 2025 | $1.3B | -6.1% |
| Q1 2025 | -$1.2B | -$734M |
| Q4 2024 | $2.5B | +35% |
| Q2 2024 | $1.4B | +47% |
BLK has the edge over CPBI on cash flow, with more consistent year-over-year improvement.
CPBI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$200K | +$566K |
| Q1 2026 | $3.5M | +$4.1M |
| Q4 2025 | $2.2M | +$3.7M |
| Q3 2025 | $888K | +$1.9M |
| Q2 2025 | -$766K | -2289% |
| Q1 2025 | -$647K | -$381K |
| Q4 2024 | -$1.5M | -165% |
| Q3 2024 | -$975K | -435% |
CPBI's free cash flow was $6M over the past year, against −$4M the year before. Free cash flow isn't a meaningful measure for financial services companies like CPBI.
BLK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -148K shares |
| 1 year | -0.4% | -677K shares |
| 3 years | +9.3% | +14M shares |
| 5 years | +6.2% | +9.6M shares |
| Available history | +4.4% | +7M shares |
BLK has the edge over CPBI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | $396M |
| Q1 2025 | $657M |
| Q4 2024 | $386M |
| Q2 2024 | $519M |
| Q1 2024 | $634M |
| Q4 2023 | $384M |
| Q3 2023 | $396M |
| Q2 2023 | $383M |
CPBI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +10.2K shares |
| 1 year | +0.5% | +17.2K shares |
| 3 years | -7.5% | -310K shares |
CPBI has 4M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $296,000 |
| Q1 2026 | $135,000 |
| Q4 2025 | $194,000 |
| Q3 2025 | $90,000 |
| Q2 2025 | $260,000 |
| Q1 2025 | $276,000 |
| Q1 2023 | — |
| Q4 2022 | — |
CPBI spent $715,000 buying back its own shares over the past year.
BLK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.0x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2024 | 0.2x | Very low |
| Q1 2024 | 0.3x | Very low |
| Q4 2023 | 0.1x | Very low |
BLK has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like BLK.
CPBI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -5.2x | Net Cash |
| Q1 2026 | -5.0x | Net Cash |
| Q4 2025 | -4.9x | Net Cash |
| Q3 2025 | -1.7x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -5.8x | Net Cash |
| Q4 2024 | -1.3x | Net Cash |
| Q3 2024 | -2.0x | Net Cash |
CPBI has the edge over BLK on leverage, with a lower net debt burden relative to earnings.
BLK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.5 | Neutral |
| Stochastic | 79.0 | Neutral |
BLK's weekly RSI is 64 (neutral) and its Stochastic is 79 (neutral).
CPBI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.6 | Neutral |
| Stochastic | 68.0 | Neutral |
CPBI's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).
BLK PE vs Financial Services Sector
| Metric | BLK | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 13x | 113% above |
| PE % | 97 | 63 | 34 pts above |
BLK is trading at 28x earnings, a 113% premium to the Financial Services sector's median of 13x.
CPBI PE vs Financial Services Sector
| Metric | CPBI | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 13x | 35% above |
| PE % | 63 | 41 | 22 pts above |
CPBI has the edge over BLK on valuation relative to its sector.
BLK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,128.0 | 7.9% above |
| 20 week MA | $1,108.9 | 9.7% above |
| 50 week MA | $1,071.6 | 14% above |
| 100 week MA | $1,051.1 | 16% above |
| 200 week MA | $914.1 | 33% above |
CPBI has stronger trend alignment. BLK is above 5 of 5 weekly averages versus CPBI above 4 of 4.
CPBI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.4 | 1.9% above |
| 20 week MA | $20.5 | 1.4% above |
| 50 week MA | $18.7 | 11% above |
| 100 week MA | $17.0 | 22% above |
CPBI is in an uptrend: it's above all four of its weekly moving averages, and 22% above its 100-week average.
BLK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $503.0 | $707.2 | +41% |
| 2021 | $707.2 | $913.9 | +29% |
| 2022 | $913.9 | $703.9 | -23% |
| 2023 | $703.9 | $811.8 | +15% |
| 2024 | $811.8 | $1,044.2 | +29% |
| 2025 | $1,044.2 | $1,088.1 | +4.2% |
| 2026 YTD | $1,088.1 | $1,216.6 | +12% |
BLK has finished higher in five of the last six years. It's up 12% so far in 2026.
CPBI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $9.10 | $10.2 | +12% |
| 2024 | $10.2 | $14.4 | +41% |
| 2025 | $14.4 | $16.9 | +17% |
| 2026 YTD | $16.9 | $20.7 | +22% |
CPBI has the edge over BLK on returns for 2026, with the stronger performance.